aod9604 AOD-9604 Peptide tested materials for laboratory and scientific research applications. AOD 9604 (5mg) - LGI

The MOTS-c analog CB4211 was well-tolerated in a Phase 1 trial with 85 participants and no serious adverse events

Some people notice mild soreness at the injection site, which typically resolves within a day

Enhances Metabolism Lipotropic agents (MIC) help the liver break down and process fat more effectively, supporting metabolic health and body composition

These injections have been used successfully in combination with weight loss programs for over 30 years

The result confirms the cyclic loop is intact and the peptide has not undergone reduction or scrambling during synthesis, purification, or lyophilization

Farmers marketssuch as the ones at Courthouse and Ballstonoffer excellent access to fresh, local produce and proteins, making healthy eating more convenient and enjoyable